Development and Validation of Genotoxic Impurity in Esomeprazole Magnesium Trihydrate Active Pharmaceutical Ingredient by LC-MS/MS
Suresh Reddy Yelampalli1★, Venkata Shanmukha Kumar Jagarlapudi1, Useni Reddy Mallu2★ Corresponding author
- 1Department of Chemistry, K.L. Educational foundation (Deemed to be K.L. University), Vijayawada, Andhra Pradesh, INDIA.
- 2Manasa Life Sciences, Hyderabad, Telangana, INDIA.
CORRESPONDENCE
Suresh Reddy Yelampalli
Department of Chemistry, K.L. Educational foundation (Deemed to be K.L. University), Vijayawada, Andhra Pradesh, INDIA.
Received: 05-05-2019; Revised: 04-09-2019; Accepted: 21-09-2019.
Volume 53, Issue 4S · pp. s642–s649 · PUBLISHED 2019 · DOI: 10.5530/ijper.53.4s.160
ABSTRACT
Objectives: A rapid, sensitive and selective analytical method has been developed and validated by liquid chromatography tandem Mass spectrometry (LC-MS/MS) for the quantification of traces of Cumene Hydroperoxide in Esomeprazole magnesium trihydrate active pharmaceutical ingredient. Materials and Methods: The chromatographic separation was carried out on a Develosil Phenyl phase-UG-5 150 x 4.6mm, 3μm column. The mobile phase consisting of 1% Ammonia solution buffer and acetonitrile, the flow rate was 0.9 mL/min with isocratic elution. Results: The retention time of Cumene Hydroperoxide was found 9.25 mins. The developed method was validated according to ICH guidelines. The system suitability was found 4.8% RSD and the linearity calibration curve was linear over the concentration range of 2.309 ppm to 12.747 ppm (r = 0.999). The intraday and inter-day precision (RSD %) was 2.1% and the obtained recovery (%) was at LOQ to 150% is in between 92.4% to 102.8% respectively. Conclusion: The low RSD values and high recoveries of the method confirms the suitability of the method for quantification of Cumene Hydroperoxide in Esomeprazole magnesium trihydrate API.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Yelampalli, S. R., Jagarlapudi, V. S. K., & Mallu, U. R. (2019). Development and Validation of Genotoxic Impurity in Esomeprazole Magnesium Trihydrate Active Pharmaceutical Ingredient by LC-MS/MS. Indian Journal of Pharmaceutical Education and Research, 53(4S), s642–s649. https://doi.org/10.5530/ijper.53.4s.160
